Terms: = Lymphoma AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Prognosis
21 results:
1. Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.
Mishina T; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yamada K; Moritsubo M; Inoue-Mitsuyama K; Shimasaki Y; Imamoto T; Kawamoto K; Furuta T; Kohno K; Kato K; Akashi K; Ohshima K
Pathol Res Pract; 2024 Feb; 254():155117. PubMed ID: 38262270
[TBL] [Abstract] [Full Text] [Related]
2. PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma.
Brown-Burke F; Hwang I; Sloan S; Hinterschied C; Helmig-Mason J; Long M; Chan WK; Prouty A; Chung JH; Zhang Y; Singh S; Youssef Y; Bhagwat N; Chen Z; Chen-Kiang S; Di Liberto M; Elemento O; Sehgal L; Alinari L; Vaddi K; Scherle P; Lapalombella R; Paik J; Baiocchi RA
Blood Adv; 2023 Oct; 7(20):6211-6224. PubMed ID: 37327122
[TBL] [Abstract] [Full Text] [Related]
3. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
4. Identification of CXCR4 Upregulation in Diffuse Large B-Cell lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract] [Full Text] [Related]
5. foxo1 forkhead domain mutants in B-cell lymphoma lack transcriptional activity.
Sablon A; Bollaert E; Pirson C; Velghe AI; Demoulin JB
Sci Rep; 2022 Jan; 12(1):1309. PubMed ID: 35079069
[TBL] [Abstract] [Full Text] [Related]
6. High grade B-cell lymphoma with
Ferrari A; Arniani S; Crescenzi B; Ascani S; Flenghi L; Pierini V; Moretti M; Beacci D; Romoli S; Bardelli V; Calistri D; Martinelli G; Mecucci C; La Starza R
Leuk Lymphoma; 2022 Jun; 63(6):1356-1362. PubMed ID: 35045798
[TBL] [Abstract] [Full Text] [Related]
7. Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma.
Xue K; Wu JC; Li XY; Li R; Zhang QL; Chang JJ; Liu YZ; Xu CH; Zhang JY; Sun XJ; Gu JJ; Guo WJ; Wang L
Cell Death Dis; 2021 Oct; 12(10):900. PubMed ID: 34599153
[TBL] [Abstract] [Full Text] [Related]
8. c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
Bouroumeau A; Bussot L; Bonnefoix T; Fournier C; Chapusot C; Casasnovas O; Martin L; McLeer A; Col E; David-Boudet L; Lefebvre C; Algrin C; Raskovalova T; Jacob MC; Vettier C; Chevalier S; Callanan MB; Gressin R; Emadali A; Sartelet H
J Pathol Clin Res; 2021 Nov; 7(6):604-615. PubMed ID: 34374220
[TBL] [Abstract] [Full Text] [Related]
9. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.
Debackere K; Marcelis L; Demeyer S; Vanden Bempt M; Mentens N; Gielen O; Jacobs K; Broux M; Verhoef G; Michaux L; Graux C; Wlodarska I; Gaulard P; de Leval L; Tousseyn T; Cools J; Dierickx D
Nat Commun; 2021 Jun; 12(1):3705. PubMed ID: 34140493
[TBL] [Abstract] [Full Text] [Related]
10. Involvement of Blnk and foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cells.
Zhang P; Wang Y; Qin M; Li D; Odhiambo WO; Yuan M; Lv Z; Liu C; Ma Y; Dong Y; Ji Y
Oncol Rep; 2021 Feb; 45(2):693-705. PubMed ID: 33416167
[TBL] [Abstract] [Full Text] [Related]
11. MiRNA-584 suppresses the progression of NK/T-cell lymphoma by targeting foxo1.
Wang CC; Han L; Hou YH; Ying XY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4404-4411. PubMed ID: 32373978
[TBL] [Abstract] [Full Text] [Related]
12. Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.
Umakanthan JM; Iqbal J; Batlevi CL; Bouska A; Smith LM; Shostrom V; Nutsch H; William BM; Gregory Bociek R; Lunning M; Bierman P; Younes A; Armitage JO; Vose JM
Br J Haematol; 2019 Mar; 184(5):744-752. PubMed ID: 30520026
[TBL] [Abstract] [Full Text] [Related]
13. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
Devan J; Janikova A; Mraz M
Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
[TBL] [Abstract] [Full Text] [Related]
14. Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis.
Zang S; Li J; Yang H; Zeng H; Han W; Zhang J; Lee M; Moczygemba M; Isgandarova S; Yang Y; Zhou Y; Rao A; You MJ; Sun D; Huang Y
J Clin Invest; 2017 Aug; 127(8):2998-3012. PubMed ID: 28691928
[TBL] [Abstract] [Full Text] [Related]
15. Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-foxo1 pathway.
Han J; Jin R; Zhang M; Guo Q; Zhou F
J Leukoc Biol; 2017 Mar; 101(3):675-681. PubMed ID: 27707884
[TBL] [Abstract] [Full Text] [Related]
16. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract] [Full Text] [Related]
17. BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.
Urban BC; Collard TJ; Eagle CJ; Southern SL; Greenhough A; Hamdollah-Zadeh M; Ghosh A; Poulsom R; Paraskeva C; Silver A; Williams AC
Gut; 2016 Jul; 65(7):1151-64. PubMed ID: 26033966
[TBL] [Abstract] [Full Text] [Related]
18. High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.
Bonvini P; Zin A; Alaggio R; Pawel B; Bisogno G; Rosolen A
Br J Cancer; 2013 Dec; 109(12):3084-91. PubMed ID: 24149177
[TBL] [Abstract] [Full Text] [Related]
19. Anaplastic lymphoma kinase status in rhabdomyosarcomas.
Yoshida A; Shibata T; Wakai S; Ushiku T; Tsuta K; Fukayama M; Makimoto A; Furuta K; Tsuda H
Mod Pathol; 2013 Jun; 26(6):772-81. PubMed ID: 23307059
[TBL] [Abstract] [Full Text] [Related]
20. Detection of PAX3/PAX7-fkhr fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation.
Yang XL; Zhang SC; Zhang SW; Wang H
Ann Diagn Pathol; 2012 Apr; 16(2):107-11. PubMed ID: 22197543
[TBL] [Abstract] [Full Text] [Related]
[Next]
